Trinity Financial Advisors LLC Bristol Myers Squibb CO Transaction History

Trinity Financial Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 24, 2022	BUY	$0.13 - $76.84 $482 - $285,076	3,710 New	3,710 $264,000
Q2 2022 Jul 22, 2022	SELL	$72.62 - $79.98 $269,420 - $296,725	-3,710 Closed	0 $0
Q1 2022 Apr 27, 2022	SELL	$61.48 - $73.72 $6,148 - $7,372	-100 Reduced 2.62%	3,710 $271,000
Q4 2021 Jan 18, 2022	SELL	$53.63 - $62.52 $26,815 - $31,260	-500 Reduced 11.6%	3,810 $238,000
Q2 2021 Oct 20, 2021	SELL	$61.91 - $67.42 $1,300 - $1,415	-21 Reduced 0.48%	4,310 $288,000
Q1 2021 Oct 20, 2021	BUY	$59.34 - $66.74 $59 - $66	1 Added 0.02%	4,331 $273,000
Q4 2020 Oct 20, 2021	BUY	$57.74 - $65.43 $250,014 - $283,311	4,330 New	4,330 $269,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Trinity Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Trinity Financial Advisors LLC with notifications on news.